Hironobu Toda Selected Research

Hironobu Toda Research Topics

4	Pathologic Constriction (Stenosis) 04/2023 - 01/2021
4	Heart Failure 01/2022 - 02/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2013
2	Non-alcoholic Fatty Liver Disease 05/2024 - 01/2021
2	Acute Coronary Syndrome 05/2024 - 01/2022
2	Inflammation (Inflammations) 04/2023 - 01/2022
2	Stroke (Strokes) 01/2023 - 01/2013
2	Myocardial Infarction 01/2023 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
2	Diabetes Mellitus 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 11/2021 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2013
1	Ischemia 08/2023
1	Peripheral Arterial Disease 01/2023
1	Glycosuria 01/2022
1	Death (Near-Death Experience) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Atrial Fibrillation 11/2021
1	Hypotension (Low Blood Pressure) 11/2021
1	Proteinuria 01/2019
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2019
1	Angina Pectoris 01/2016
1	Thrombosis (Thrombus) 01/2013
1	Hemorrhage 01/2013

3	omega-Chloroacetophenone (Mace)IBA 05/2024 - 01/2013
3	CalciumIBA 04/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2019
3	Phenobarbital (Luminal)FDA Link 12/2022 - 01/2021
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 01/2020
3	voglibose (Basen)IBA 01/2022 - 01/2020
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2020
2	Bisoprolol (Concor)FDA LinkGeneric 11/2021 - 01/2020
1	LipidsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	DiureticsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Glycoside Hydrolase InhibitorsIBA 01/2022
1	SodiumIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	SymportersIBA 01/2022
1	AdiponectinIBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Tolvaptan FDA Link 02/2016
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2013
1	zotarolimusIBA 01/2013

3	Therapeutics 01/2019 - 01/2013
1	Catheters 08/2023
1	Surgical Amputation (Amputations) 01/2023
1	Exercise Therapy (Therapy, Exercise) 01/2023
1	Stents 01/2013
1	Percutaneous Coronary Intervention 01/2013